Aimei Health Technology Reports on Extraordinary General Meeting

On December 23, 2024, Aimei Health Technology Co., Ltd (NASDAQ: AFJKU) convened an extraordinary general meeting for its shareholders to discuss several important proposals. This meeting was held at the company’s legal counsel office in New York and was also accessible online to facilitate broader participation.

One of the primary matters addressed during the meeting was the Trust Agreement Amendment Proposal. This proposal aimed to revise the funds to be allocated into the Trust Account with the intention of extending the deadline for an initial business combination. However, the proposal did not pass, receiving only 29.71% votes in favor, while 51.81% of shareholders voted against it. The remaining 8.94% chose to abstain from the vote.

In addition, the shareholders also voted on the Adjournment Proposal, which sought to defer the current meeting to allow for the collection of more proxy votes, if necessary, concerning the Trust Agreement Amendment Proposal. Similar to the previous proposal, this adjournment did not receive the required support. Results showed that only 32.16% of the votes supported the adjournment, whereas 49.36% opposed it, with another 8.94% abstaining.

At the time of the extraordinary general meeting, Aimei Health Technology had a total of 9,026,000 ordinary shares issued and outstanding. Shareholders actively participated in the voting process regarding the proposals put forth by the company. The terms used were clearly defined in the proxy statement that was distributed prior to the meeting.

As a growing company in the market, Aimei Health Technology provided details of the meeting's outcomes in compliance with the SEC filing regulations, specifically through Form 8-K. The company continues to prepare for future regulatory compliance and strategic business decisions as it develops.

This summary is generated from available information and reflects the proceedings of the extraordinary general meeting. For further details, shareholders can refer to Aimei Health Technology's official 8-K filing.

Company Overview of Aimei Health Technology

Aimei Health Technology Co., Ltd is currently not engaged in significant operational activities. Its primary focus is to pursue options for merger, asset acquisition, or business combination opportunities, particularly in sectors related to biopharmaceuticals and medical technology.

meeting, shareholders, proposals